SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-068301
Filing Date
2022-06-06
Accepted
2022-06-06 07:00:52
Documents
14
Period of Report
2022-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2217741d1_8k.htm   iXBRL 8-K 43914
2 EXHIBIT 99.1 tm2217741d1_ex99-1.htm EX-99.1 25446
6 GRAPHIC tm2217741d1_ex99-1img002.jpg GRAPHIC 6230
  Complete submission text file 0001104659-22-068301.txt   265957

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hook-20220605.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20220605_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20220605_pre.xml EX-101.PRE 22605
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2217741d1_8k_htm.xml XML 3750
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 22996685
SIC: 2834 Pharmaceutical Preparations